文献速递系统性红斑狼疮

抗核抗体用于系统性红斑狼疮分类的性能:系统文献综述与诊断数据Meta回归

Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Data.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-01-30

该系统综述与Meta回归评估间接免疫荧光(IIF)HEp-2抗核抗体(ANA)对系统性红斑狼疮(SLE)分类的性能,纳入62篇文献共13,080例SLE患者,其中12,542例(95.9%)IIF-ANA阳性。Meta回归显示ANA滴度1:80时敏感性97.8%(95%CI 96.8-98.5%)、特异性74.7%(95%CI 66.7-81.3%),支持将1:80作为SLE分类的准入标准。

要点

  • IIF-ANA对SLE总体敏感性高,13,080例SLE患者中95.9%为IIF-ANA阳性。
  • ANA滴度1:80敏感性97.8%(95%CI 96.8-98.5%),特异性74.7%(95%CI 66.7-81.3%)。
  • 建议以ANA≥1:80作为SLE分类准入标准,达标后再行其他分类标准检测。

核心结论

  • IIF-ANA对SLE具有高敏感性,支持将ANA滴度1:80作为SLE分类标准的准入条件。

研究设计与样本

  • 共筛选4,483篇文献,62篇符合纳入标准,另经参考文献分析补充2篇。
  • 纳入研究共含13,080例SLE患者,其中12,542例(95.9%)报告为IIF-ANA阳性(各滴度)。

主要发现

  • ANA滴度1:40时敏感性98.4%(95%CI 97.6-99.0%)、特异性66.9%(95%CI 57.8-74.9%)。
  • ANA滴度1:80时敏感性97.8%(95%CI 96.8-98.5%)、特异性74.7%(95%CI 66.7-81.3%)。
  • ANA滴度1:160时敏感性95.8%(95%CI 94.1-97.1%)、特异性86.2%(95%CI 80.4-90.5%)。
  • ANA滴度1:320时敏感性86.0%(95%CI 77.0-91.9%)、特异性96.6%(95%CI 93.9-98.1%)。

关键数值与推荐

  • ANA滴度1:80具有足够高的敏感性,可考虑作为SLE分类标准的准入标准。
  • 仅当检出ANA至少1:80时,才正式检测其他SLE分类标准。

临床怎么用

  • 临床怀疑SLE时,可依据IIF-ANA≥1:80作为进一步分类评估的准入条件。
  • ANA滴度升高至1:160或1:320时特异性提高,但敏感性下降,需结合临床综合判断。

局限性

  • 纳入研究间异质性可能影响Meta回归结果,原文未报告异质性量化指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To review the published literature on the performance of indirect immunofluorescence (IIF)-HEp-2 antinuclear antibody (ANA) testing for classification of systemic lupus erythematosus (SLE). METHODS: A systematic literature search was conducted in the Medline, Embase, and Cochrane databases for articles published between January 1990 and October 2015. The research question was structured according to Population, Intervention, Comparator, Outcome (PICO) format rules, and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations were followed where appropriate. Meta-regression analysis for diagnostic tests was performed, using the ANA titer as independent variable, while sensitivity and specificity were dependent variables. RESULTS: Of 4,483 publications screened, 62 matched the eligibility criteria, and another 2 articles were identified through reference analysis. The included studies comprised 13,080 SLE patients in total, of whom 12,542 (95.9%) were reported to be IIF-ANA positive at various titers. For ANA at titers of 1:40, 1:80, 1:160, and 1:320, meta-regression gave sensitivity values of 98.4% (95% confidence interval [95% CI] 97.6-99.0%), 97.8% (95% CI 96.8-98.5%), 95.8% (95% CI 94.1-97.1%), and 86.0% (95% CI 77.0-91.9%), respectively. The corresponding specificities were 66.9% (95% CI 57.8-74.9%), 74.7% (95% CI 66.7-81.3%), 86.2% (95% CI 80.4-90.5%), and 96.6% (95% CI 93.9-98.1%), respectively. CONCLUSION: The results of this systematic literature review and meta-regression confirm that IIF-ANAs have high sensitivity for SLE. ANAs at a titer of 1:80 have sufficiently high sensitivity to be considered as an entry criterion for SLE classification criteria, i.e., formally test other classification criteria for SLE only if ANAs of at least 1:80 have been found.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Leuchten N, Hoyer A, Brinks R, et al. Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Data. Arthritis Care Res (Hoboken). 2018. PMID: 28544593. doi:10.1002/acr.23292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。